• Nie Znaleziono Wyników

The Voice of the Editor-in-Chief

N/A
N/A
Protected

Academic year: 2022

Share "The Voice of the Editor-in-Chief"

Copied!
1
0
0

Pełen tekst

(1)

1

www.dk.viamedica.pl

The Voice of the Editor-in-Chief

Dear Colleagues,

Since several years, the journal „Diabetologia Kliniczna” has been the official journal of the Polish Diabetes Association endeavouring to carry out both scientific and educational missions. Combining these two approaches is not always easy, particularly in the era of increasing expectations related to scientific jour- nals’ indexation and impact. Taking this into account, the Editor-in-Chief of the journal and the Main Board of the Polish Diabetes Association in cooperation with the Publisher decided to transform this bimonthly into „Clinical Diabetology”, a journal published fully in English with free on-line access. Currently, this is a necessary and primary condition for further scientific development of the journal, increasing the number of readers and gaining the cooperative participation

of international authors and reviewers, and finally for introducing the „Clinical Diabetology” journal in PubMed and Medline databases. At the same time, we intend to continue the educational function of the journal and we do not want to hinder the access to its content for the readers; therefore, we decided to issue Polish version of the journal, under the for- mer title „Diabetologia Praktyczna”, that will contain reprints from English version and, increasingly, other materials directed exclusively to Polish readers. We hope that the journal in a new form will continue the good tradition of the printed version and maintain the quality level that was ensured for many years by the first Editor-in-Chief of „Diabetologia Praktyczna”, Professor Jacek Sieradzki.

Hoping for your kind understanding. Best regards

Editor-in-Chief Prof. Janusz Gumprecht President of the Polish Diabetes Association Prof. Maciej Małecki

Cytaty

Powiązane dokumenty

At the beginning of October, annual meeting of European Association for the Study of Diabetes (EASD) will be held in Berlin, and one of the most awaited events during this

Among papers included in this issue of “Clinical Diabetology”, it is worth paying attention to a multi- centre study conducted in 2013–2017 in women with type 1 diabetes who,

As the practical management of patients with diabetes should be based primarily on knowledge derived from Evidence Based Medicine (EBM), the reference to the EBM

I would like to draw your attention to the problem of diabetes care quality discussed by researchers from Libya, an interesting case report of the use of hydroxychloroquine in type

Many interesting reports presented during the Congress addressed, among others, epidemiology, new possibilities of molecular biology, measurable effects of translating basic

Following the publication of the results of already completed Cardiovascular Outcome Trials (CVOTs) on new molecules used in the treatment of diabetes, there is no doubt that

In the InTandem3 study (Study to Evaluate the Safety of So- tagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycaemic Control With Insulin Therapy Alone) with

In addition to attending the scientific meetings, I also encourage you to read the latest issue of the “Clinical Diabetology”, where, among a number of interesting articles, I would